About Hi-Tech
Hi-Tech was established in 1983 in Amityville, United States, within the pharmaceutical sector. Operations centered on producing generic, branded, and OTC items, with emphasis on liquid and semi-solid dosage forms such as solutions, suspensions, creams, nasal sprays, gels, ophthalmics, and ointments. A dedicated healthcare division managed OTC products, while subsidiary ECR Pharmaceuticals oversaw branded formulations. Acquisition by Akorn Pharma took place in 2013.
- Headquarter Amityville, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Hi-Tech
Detailed funding history for Hi-Tech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Hi-Tech
Hi-Tech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Akorn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas.
|
Locked | Locked | Locked |
Investor details for Hi-Tech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hi-Tech
Investment portfolio details for Hi-Tech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hi-Tech
Detailed financials for Hi-Tech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hi-Tech Comparisons
Peer comparison for Hi-Tech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hi-Tech
Detailed competitors of Hi-Tech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hi-Tech
Complete news archive for Hi-Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hi-Tech
Hi-Tech was founded in 1983.
Hi-Tech is headquartered in Amityville, United States. It is registered at Amityville, New York, United States.
Hi-Tech was established in 1983 in Amityville, United States, within the pharmaceutical sector. Operations centered on producing generic, branded, and OTC items, with emphasis on liquid and semi-solid dosage forms such as solutions, suspensions, creams, nasal sprays, gels, ophthalmics, and ointments. A dedicated healthcare division managed OTC products, while subsidiary ECR Pharmaceuticals oversaw branded formulations. Acquisition by Akorn Pharma took place in 2013.
Hi-Tech has 1 investor. Key investors include Akorn.